4 results about "Protein allergy" patented technology

This invention provides a synbiotic for regulating protein allergy, an infant amino acid formula powder, and its preparation method, belonging to the field of milk powder technology. A synbiotic for regulating protein allergy comprises the following components in parts by weight: 10-30 parts of galactooligosaccharides, 1-3 parts of fructooligosaccharides, 5-15 parts of 2'-fucosylated lactose, 1-3 parts of lactose-N-neotetrasaccharide, 1-2 parts of sodium 3'-sialotyl-lactose, and 0.1-5 parts of Bifidobacterium longum subsp. infantis M-63. The synbiotic components work synergistically to deeply mimic the mechanisms of action of breast milk in building intestinal microecology, regulating immune function, and promoting digestive comfort. Combined with amino acids, nucleotides, and other nutrients, this formula is formulated into an infant amino acid formula powder, which can effectively reduce allergy symptoms and reactions, providing a scientific nutritional solution that closely approximates the physiological benefits of breast milk for allergic infants who cannot be breastfed.

The application relates to the field of cosmetics, and specifically provides a composition for improving skin aging and application and method thereof, the composition comprising cyclin-dependent kinase 1, glutathione peroxidase 5 and cellular retinoic acid binding protein 1. The composition of the application can synergistically regulate cell proliferation, antioxidation and retinoic acid metabolic pathways, significantly improve skin photoaging, and improve bioavailability; the three protein molecules have a molecular weight less than 35 kDa, can efficiently penetrate the stratum corneum to reach the dermis, and can greatly improve the absorption rate of external use; the protein can be obtained through human recombinant expression, the risk of animal-derived protein allergy can be effectively reduced, the protein has high safety and industrialization potential, and has wide application value.

The present invention belongs to the technical field of probiotics and their applications, and particularly relates to a Lactiplantibacillus plantarum SM1 and its applications in the preparation of foods and drugs for gastrointestinal conditioning and weight loss. In order to explore more Lactiplantibacillus plantarum with probiotic functions, the present invention isolated and purified a strain of Lactiplantibacillus plantarum SM1 from the fecal sample of a healthy adult in Guangdong region. This strain has excellent protease activity, excellent cellulase activity, can produce and secrete glutathione, can produce and secrete γ-aminobutyric acid, can inhibit α-glucosidase activity, can inhibit xanthine oxidase activity, can inhibit renin activity, and has various functions such as promoting the digestion and absorption of protein foods and improving protein allergy; promoting the absorption of cellulose and improving constipation, etc., and has important application value and economic value in the fields of gastrointestinal conditioning and weight loss.

The present invention relates to synthetic and / or recombinant consensus allergens and to their use as allergy vaccines in particular in the treatment of peach-cypress allergy, in the form of an allergy vaccine comprising a consensus allergen and / or a nucleic acid sequence encoding such, wherein the consensus allergen comprises at least (60) amino acids and is derived from a consensus sequence of the amino acid sequences of at least five (5) protein allergens, and wherein said protein allergens share at least 20% amino acid sequence identity.